Filing Details

Accession Number:
0001181431-10-001309
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-05 12:00:00
Reporting Period:
2009-12-31
Filing Date:
2010-01-05
Accepted Time:
2010-01-05 17:33:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
889232 Ab Investor Arsenalsgatan 8C S-103
Stockholm V7
No No Yes No
1237710 Ltd Capital Growth Investor Canada Court
Upland Road, St. Peter Port
Guernsey, Channel Islands X0 GY1 3BQ
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2009-12-31 56,000 $3.21 2,119,714 No 4 S Indirect See Footnote
Common Stock Disposition 2009-12-31 39,200 $3.21 1,483,810 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Direct
Footnotes
  1. 39,200 shares of Common Stock, par value $0.001 (the "Common Stock"), were sold by Investor Growth Capital Limited and 16,800 shares of Common Stock were sold by Investor Group, L.P. The shares of Common Stock reported in Column 5 are held directly by Investor Growth Capital Limited and Investor Group, L.P. Investor Growth Capital Limited is an indirect wholly-owned subsidiary of Investor AB. Investor Group, L.P. is a limited partnership of which Investor AB is the indirect general partner. Investor AB may be deemed to beneficially own the securities held by Investor Growth Capital Limited and Investor Group, L.P. Investor AB disclaims beneficial ownership of such securities except to the extent of its pecuniary interest in such securities.
  2. These shares of Common Stock were sold by Investor Growth Capital Limited.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.13 to $3.24. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.